This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alexion Pharmaceuticals Inc (ALXN)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 1.01B 944.00M 529.86M 989.50M
Receivables 532.83M 432.89M 421.75M 295.60M
Inventories 289.87M 176.44M 102.60M 94.52M
Other Current Assets 0.00 0.00 18.93M 14.62M
Total Current Assets 2.43B 2.80B 2.19B 1.50B
Property, Plant & Equipment, Gross 873.16M 529.90M 305.21M 245.62M
Accumulated Depreciation & Depletion 176.13M 137.66M 104.11M 79.99M
Property, Plant & Equipment, Net 697.02M 392.25M 201.11M 165.63M
Intangibles 4.71B 587.05M 609.72M 646.68M
Other Non-Current Assets 255.06M 137.63M 62.54M 38.05M
Total Non-Current Assets 10.71B 1.41B 1.13B 1.12B
Liabilities & Shareholder Equity
Total Assets 13.13B 4.20B 3.32B 2.61B
Accounts Payable 112.96M 80.84M 145.89M 109.27M
Short Term Debt 175.00M 48.00M 48.00M 48.00M
Other Current Liabilities 74.12M 155.48M 228.84M 121.60M
Total Current Liabilities 718.25M 606.74M 582.43M 360.09M
Long Term Debt 3.28B 9.50M 65.00M 101.00M
Deferred Income Taxes 528.99M 7.05M 101.24M 19.83M
Other Non-Current Liabilities 194.82M 169.56M 154.72M 161.79M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 4.16B 293.20M 353.19M 282.62M
Total Liabilities 4.87B 899.94M 935.62M 642.71M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 8.26B 3.30B 2.38B 1.97B
Common Par 23.00K 20.00K 20.00K 20.00K
Additional Paid In Capital 7.73B 2.59B 2.11B 1.85B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 1.18B 1.04B 379.10M 126.20M
Treasury Stock -710.66M -382.96M -80.36M -14.23M
Other Equity Adjustments 62.30M 56.78M -22.86M 6.63M
Total Capitalization 11.54B 3.31B 2.45B 2.07B
Total Equity 8.26B 3.30B 2.38B 1.97B
Total Liabilities & Stock Equity 13.13B 4.20B 3.32B 2.61B
Total Common Shares Outstanding 225.65M 199.06M 196.96M 194.69M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 4.85M 2.89M 985.00K 227.00K
Basic Weighted Shares Outstanding 213.43M 198.10M 195.53M 190.46M
Diluted Weighted Shares Outstanding 215.93M 201.62M 199.71M 198.50M
Number of Employees 2924 2273 1774 1373
Number of Part-Time Employees 0 0 0 0
ALXN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ALXN Alexion Pharmaceuticals Inc

Chart of ALXN

Analysts Ratings for ALXN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 13 13 14 12
Moderate Buy 1 1 1 1
Hold 5 4 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ALXN ANALYST REPORT

ALXN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs